Microsoft Corporation

Circle Internet Group

Tesla, Inc.

The conflict between Ilon Musk and Donald Trump has sharply escalated: mutual public accusations and threats led to the collapse of Tesla shares by 14%. Meanwhile, Microsoft's shares reached an all-time high and put the company back in first place in the world by market capitalization - $3.48 trillion, ahead of Nvidia and Apple. At the same time, Omada Health, a startup specializing in online health programs, successfully completed its IPO: it sold shares at $19 each and received a valuation of about $1.1 billion. These and other topics are covered in our review of key events for the morning of June 6.

"Could lead to punitive measures": how Musk and Trump conflict threatens investors


Public criticism of the bill puts Tesla CEO in opposition to Trump

'Disgusting abomination': Musk harshly criticized Trump's budget bill


Palantir Technologies Inc.

The robotaxi service is scheduled to launch in Texas in June, and it largely supported Tesla stock in May

Katie Wood's funds have cut their stake in Tesla. Does she doubt the future of robotaxis?

The company, which is trying to compete with OpenAI, also plans to borrow $5 billion and may be launching a new round of investment

Musk's AI startup prepares $300 million deal to confirm $113 billion valuation


Micro-cap space services provider Sidus Space <a href="https://www.marketwatch.com/investing/stock/sidu?mod=search_symbol&amp;utm_source=in_materials">soared</a> more than 10% yesterday, Tuesday, February 4, after an announcement that the company’s third satellite had arrived at a California space facility for final preparations ahead of launch. The mission will be carried out in collaboration with SpaceX, owned by Elon Musk, Sidus <a href="https://investors.sidusspace.com/news-events/press-releases/detail/220/sidus-space-announces-lizziesat-has-arrived-at?utm_source=in_materials">noted</a>.

Space-as-a-service company Sidus jumps ahead of third satellite launch

The head of Ark Invest, Cathie Wood, has recently increased her stake in 10x Genomics, among other small-cap names, <a href="https://www.fool.com/investing/2024/12/24/cathie-wood-goes-bargain-hunting-3-stocks-she-just/?utm_source=in_materials#:~:text=3.-,10x%20%D0%93%D0%B5%D0%BD%D0%BE%D0%BC%D0%B8%D0%BA%D0%B0,%D0%B0%D0%BA%D1%86%D0%B8%D1%8F%D1%85%2C%20%D0%BA%D0%BE%D1%82%D0%BE%D1%80%D1%8B%D0%B5%20%D0%BF%D0%BE%D1%82%D0%B5%D1%80%D1%8F%D0%BB%D0%B8%20%D0%BF%D0%BE%D1%87%D1%82%D0%B8%20%D1%82%D1%80%D0%B8%20%D1%87%D0%B5%D1%82%D0%B2%D0%B5%D1%80%D1%82%D0%B8%20%D1%81%D0%B2%D0%BE%D0%B5%D0%B9%20%D1%81%D1%82%D0%BE%D0%B8%D0%BC%D0%BE%D1%81%D1%82%D0%B8%20%D0%B2%20%D1%8D%D1%82%D0%BE%D0%BC%20%D0%B3%D0%BE%D0%B4%D1%83.,-%D0%93%D0%BB%D0%B0%D0%B2%D0%BD%D1%8B%D0%BC%20%D0%BF%D0%BE%D0%B1%D0%B5%D0%B4%D0%B8%D1%82%D0%B5%D0%BB%D0%B5%D0%BC%20%D0%B2">reports</a> the Motley Fool, which said the company has been "going in the wrong direction." 10x Genomics, with a market capitalization of $1.78 billion, designs and manufactures gene sequencing technology.

Cathie Wood builds up her stake in 'disappointing' 10x Genomics — The Motley Fool

Sidus Space, a small space services company, <a href="https://www.marketwatch.com/investing/stock/sidu?utm_source=in_materials">plunged</a> over 40% in premarket trading today, November 13, after the company <a href="https://investors.sidusspace.com/news-events/press-releases/detail/208/sidus-space-announces-pricing-of-public-offering?utm_source=in_materials">announced</a> it would sell 5.6 million new shares at $1.25 each. This is the lowest price Sidus shares have ever been offered to investors.

Sidus Space shares plummet after share offer with 45% discount announced

"In my entire life, I never dreamed that we would be talking about medicines that are providing hope for people like me who have struggled for years with being overweight or with obesity," famous TV host Oprah Winfrey <a href="https://people.com/celebrities-ozempic-wegovy-what-theyve-said-7104926">told</a> magazine two and a half years after Novo Nordisk's weight-loss drug Wegovy hit the market. Currently, Wegovy and Zepbound, made by U.S.-based Eli Lilly, account for 95% of the obesity market. In the upcoming years, however, they may face over a dozen new competitors. Which companies should investors keep an eye on in the space?

The skinny on investing in the weight-loss drug market

Shares of Sidus Space, a space services company, <a href="https://www.nasdaq.com/market-activity/stocks/sidu">plummeted</a> around 16% in trading on Tuesday, October 15, following the <a href="https://ir.stockpr.com/sidusspace/sec-filings-email/content/0001493152-24-041072/forms-1.htm">announcement</a> of the company’s third stock offering this year. The latest is expected to nearly double the company's outstanding shares.

Sidus Space sells off after new stock offering announced

Nearly 220 years ago, in January 1802, a heinous crime was committed in London. A certain George Forster murdered his wife and child, discarding their bodies in a canal. While Forster's conflicts with his wife were well-known, it was the immediate discovery of her body contrasted with the three-day search for the child in the water that gripped the public. Witness testimonies, albeit imperfect by later standards, exposed the criminal who was sentenced to hanging. In accordance with the practices of the time, after the sentence was carried out, blood was released from his body, and his spine was cut in several places to ensure the efficacy of the execution.